Results 1 to 10 of about 40,543 (156)
Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers
Vaccines, 2021 COVID-19 (coronavirus disease 2019) vaccines induce immunity through different mechanisms. The aim of this study is to compare the titers of specific antibodies in subjects vaccinated with either the Pfizer-BioNTech COVID-19 vaccine or the Sinopharm ...
Rami Al Qassieh +2 more
exaly +3 more sources
Vaccines, 2022 Background: Awareness about the COVID-19 vaccine’s adverse effects is crucial for gaining public trust. As we still lack proof of vaccines’ safety, this survey aimed to investigate Egyptians’ general awareness of the Sinopharm and AstraZeneca vaccines ...
Marian S Boshra +2 more
exaly +3 more sources
HeliyonCOVID-19 is a highly contagious infectious disease that has posed a global threat, leading to a widespread pandemic characterized by multi-organ complications and failures.
Lina A Dahabiyeh +2 more
exaly +3 more sources
Journal of Diabetes Research, 2022 The risk of cardiovascular diseases is closely related to diabetes. Macrovascular disease is the main cause of death and disability in patients with type 2 diabetes.
Rui Song +12 more
doaj +1 more source
Research Progress on the GIP/GLP-1 Receptor Coagonist Tirzepatide, a Rising Star in Type 2 Diabetes
Journal of Diabetes Research, 2023 Type 2 diabetes mellitus (T2DM) is a chronic progressive metabolic disease that has become a growing health problem worldwide, and the dangers of hyperglycemia and its chronic complications have long been considered a goal of diabetes treatment.
Zijun Ma +4 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2023 The rising need for repeated booster vaccinations against SARS-CoV-2 infections raises the question of whether chronic immunosuppressive chemotherapies influence the efficacy of vaccination. Here, we present the case of a 70-year-old post-thymoma surgery
Akos Koller, János Szebeni
doaj +1 more source
Comparison of the Antibody Responses Following Vaccination with AstraZeneca and Sinopharm [PDF]
Iranian Journal of Immunology, 2022 Background: Vaccines are the most effective way to prevent Coronavirus 2 severe acute respiratory syndrome (SARS-CoV-2).Objectives: To compare the antibody response of healthy individuals vaccinated with either the AstraZeneca (ChAdOx1 nCoV-19) or the ...
Enayat Anvari +8 more
doaj +1 more source
Post COVID-19 vaccination Guillain-Barre syndrome: three cases
Human Vaccines & Immunotherapeutics, 2022 Guillain-Barré syndrome (GBS) is an acute inflammatory polyradiculoneuropathy. In two-thirds of patients, it is preceded by an upper respiratory or gastrointestinal tract infection.
Seyedehnarges Tabatabaee +6 more
doaj +1 more source
Zhongguo shuxue zazhi, 2023 Objective To determine the best collection time period of plasma which can be used for human COVID-19 immunoglobulin for intravenous injection through SARS-CoV-2-IgG change and neutralizing antibody distribution against different virus strain in ...
Zhijun ZHOU +12 more
doaj +1 more source
Biomedical and Biotechnology Research Journal, 2022 Background: Due to increased vaccination rates and the continued spread of the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus, many people are developing “hybrid immunity” to the virus.
Rawaq Taleb Hassan, Suhad Hadi Mohammed
doaj +1 more source